October 5, 2020 10:24 AM EDTUpdated 01:28 PM

News briefing: Kronos Bio sets terms for IPO, flirting with billion-dollar unicorn valuation; Corvus collabs with spinout, unveils positive Covid-19 data

Kronos Bio announced it’s looking to raise more than $200 million in its jump onto Nasdaq, flirting with a billion …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

News brief­ing: Kro­nos Bio sets terms for IPO, flirt­ing with bil­lion-dol­lar uni­corn val­u­a­tion; Corvus col­labs with spin­out, un­veils pos­i­tive Covid-19 da­ta